Jupiter Life Line Hospitals (JLHL) Q4 20/21 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 20/21 earnings summary
16 Oct, 2026Executive summary
FY21 revenue was broadly flat YoY, while profit before tax, net profit and EPS declined; COVID-19 lockdowns hit Q1 results.
Operations spanned multi-specialty hospitals in Thane and Pune, with a hotel supporting medical tourism.
Financial highlights
Revenue from operations was ₹46,109.55 lakh vs ₹46,294.52 lakh; total revenue was ₹46,512.43 lakh vs ₹46,483.13 lakh.
Total expenses rose to ₹44,757.50 lakh from ₹43,194.17 lakh; finance costs were ₹2,817.00 lakh vs ₹2,568.71 lakh.
PBT was ₹1,754.93 lakh vs ₹3,288.96 lakh; net profit was ₹1,659.31 lakh vs ₹2,963.40 lakh.
Operating cash flow was ₹11,314.89 lakh vs ₹7,460.27 lakh; net cash increased ₹1,150.35 lakh vs a ₹92.74 lakh decrease.
Segment performance
Hospital IP collections were ₹37,625.39 lakh vs ₹35,786.13 lakh; OP collections were ₹7,973.39 lakh vs ₹9,390.27 lakh.
Hotel collections were ₹273.23 lakh vs ₹898.59 lakh; other revenue was ₹237.54 lakh vs ₹219.53 lakh.
Hospital capacity comprised 350 beds in Thane and 220 beds in Pune; Fortune Park Lake City operated in collaboration with ITC Hotels.
Latest events from Jupiter Life Line Hospitals
- Revenue advanced, but H1 profit eased as capacity expansion moved ahead.JLHL
Q2 26/27 - FY2023 profit rose as hospital revenues grew and IPO preparations advanced.JLHL
Q4 22/23 - FY22 revenue and profit advanced as COVID costs coincided with hospital expansion plans.JLHL
Q4 21/22 - H1 income grew 19.8%, debt was repaid, and Indore reached EBITDA break-even.JLHL
Q2 23/24 - Occupancy climbed and debt was cleared, while PAT benefited from a deferred-tax credit.JLHL
Q1 23/24 - Q1 FY27 revenue grew 16.2% to ₹4,109.83 million, with margin pressure from expansion.JLHL
Q1 26/27 - Q1 FY25 saw strong revenue and EBITDA growth, digital accreditation, and capacity expansion.JLHL
Q1 24/25 - Q3 FY26 income and EBITDA rose, but PAT fell due to labor code; major hospital expansion underway.JLHL
Q3 25/26 - Strong revenue and profit growth, major hospital expansion, and robust internal funding.JLHL
Q3 24/25